Moderna, Inc. (LON:0A45)

Bally's Statistics

Total Valuation

Moderna has a market cap or net worth of GBP 8.11 billion. The enterprise value is 2.97 billion.

Market Cap	8.11B
Enterprise Value	2.97B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	389.08M
Shares Outstanding	n/a
Shares Change (YoY)	+1.05%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	360.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.61
PB Ratio	1.18
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.40
EV / Sales	1.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.17

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.07.

Current Ratio	3.93
Quick Ratio	3.29
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-136.38

Financial Efficiency

Return on equity (ROE) is -27.50% and return on invested capital (ROIC) is -17.73%.

Return on Equity (ROE)	-27.50%
Return on Assets (ROA)	-14.78%
Return on Invested Capital (ROIC)	-17.73%
Return on Capital Employed (ROCE)	-31.36%
Revenue Per Employee	387,350
Profits Per Employee	-365,328
Employee Count	5,800
Asset Turnover	0.22
Inventory Turnover	16.52

Taxes

Income Tax	-30.66M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.36% in the last 52 weeks. The beta is 1.85, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	1.85
52-Week Price Change	-71.36%
50-Day Moving Average	29.25
200-Day Moving Average	34.61
Relative Strength Index (RSI)	36.91
Average Volume (20 Days)	61,982

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.07

Income Statement

In the last 12 months, Moderna had revenue of GBP 2.25 billion and -2.12 billion in losses. Loss per share was -5.49.

Revenue	2.25B
Gross Profit	-1.61B
Operating Income	-2.39B
Pretax Income	-2.15B
Net Income	-2.12B
EBITDA	-2.24B
EBIT	-2.39B
Loss Per Share	-5.49

Balance Sheet

The company has 3.75 billion in cash and 509.47 million in debt, giving a net cash position of 4.97 billion.

Cash & Cash Equivalents	3.75B
Total Debt	509.47M
Net Cash	4.97B
Net Cash Per Share	n/a
Equity (Book Value)	6.86B
Book Value Per Share	17.68
Working Capital	3.36B

Cash Flow

In the last 12 months, operating cash flow was -1.97 billion and capital expenditures -578.81 million, giving a free cash flow of -2.55 billion.

Operating Cash Flow	-1.97B
Capital Expenditures	-578.81M
Free Cash Flow	-2.55B
FCF Per Share	n/a

Margins

Gross margin is -71.44%, with operating and profit margins of -106.34% and -94.31%.

Gross Margin	-71.44%
Operating Margin	-106.34%
Pretax Margin	-95.68%
Profit Margin	-94.31%
EBITDA Margin	-99.58%
EBIT Margin	-106.34%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.05%
Shareholder Yield	-1.05%
Earnings Yield	-26.13%
FCF Yield	-31.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 5.27 and a Piotroski F-Score of 1.

Altman Z-Score	5.27
Piotroski F-Score	1